Biosig Technologies (BSGM) Competitors $6.34 +1.90 (+42.58%) Closing price 09/11/2025Extended Trading$6.34 0.00 (0.00%) As of 09/11/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BSGM vs. ZIMV, KIDS, TMCI, CBLL, SMLR, DCTH, BFLY, RXST, CARL, and SNWVShould you be buying Biosig Technologies stock or one of its competitors? The main competitors of Biosig Technologies include ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), CeriBell (CBLL), Semler Scientific (SMLR), Delcath Systems (DCTH), Butterfly Network (BFLY), RxSight (RXST), Carlsmed (CARL), and Sanuwave Health (SNWV). These companies are all part of the "medical equipment" industry. Biosig Technologies vs. Its Competitors ZimVie OrthoPediatrics Treace Medical Concepts CeriBell Semler Scientific Delcath Systems Butterfly Network RxSight Carlsmed Sanuwave Health Biosig Technologies (NASDAQ:BSGM) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation. Which has preferable valuation & earnings, BSGM or ZIMV? Biosig Technologies has higher earnings, but lower revenue than ZimVie. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiosig Technologies$13K15,334.89-$10.33MN/AN/AZimVie$449.75M1.18-$25.83M-$0.70-26.99 Do insiders & institutionals have more ownership in BSGM or ZIMV? 7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 95.6% of ZimVie shares are owned by institutional investors. 24.8% of Biosig Technologies shares are owned by company insiders. Comparatively, 5.4% of ZimVie shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is BSGM or ZIMV more profitable? Biosig Technologies has a net margin of 0.00% compared to ZimVie's net margin of -4.39%. ZimVie's return on equity of 6.37% beat Biosig Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Biosig TechnologiesN/A -5,336.99% -90.03% ZimVie -4.39%6.37%3.34% Do analysts prefer BSGM or ZIMV? Biosig Technologies presently has a consensus price target of $10.00, indicating a potential upside of 57.60%. ZimVie has a consensus price target of $17.75, indicating a potential downside of 6.03%. Given Biosig Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Biosig Technologies is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biosig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ZimVie 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, BSGM or ZIMV? Biosig Technologies has a beta of 1.82, indicating that its share price is 82% more volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.2, indicating that its share price is 120% more volatile than the S&P 500. Does the media refer more to BSGM or ZIMV? In the previous week, Biosig Technologies and Biosig Technologies both had 5 articles in the media. ZimVie's average media sentiment score of 1.16 beat Biosig Technologies' score of 0.76 indicating that ZimVie is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biosig Technologies 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ZimVie 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryBiosig Technologies beats ZimVie on 7 of the 13 factors compared between the two stocks. Get Biosig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBiosig TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$199.35M$6.78B$5.80B$10.16BDividend YieldN/A1.21%5.72%4.60%P/E RatioN/A25.8475.1326.39Price / Sales15,334.89194.57508.32174.86Price / CashN/A22.1825.8129.91Price / Book-70.504.9413.716.28Net Income-$10.33M$176.38M$3.29B$270.38M7 Day Performance54.38%4.58%0.07%1.89%1 Month Performance27.67%7.06%4.57%6.01%1 Year Performance1,330.67%10.95%78.24%25.26% Biosig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBiosig Technologies2.0495 of 5 stars$6.35+42.6%$10.00+57.6%+1,316.9%$199.35M$13K0.0050Gap DownHigh Trading VolumeZIMVZimVie1.2347 of 5 stars$18.89+0.2%$17.75-6.0%+14.8%$531.77M$449.75M-26.991,770Positive NewsKIDSOrthoPediatrics4.332 of 5 stars$20.91flat$34.14+63.3%-39.4%$524.29M$204.73M-11.68200Positive NewsTMCITreace Medical Concepts2.5691 of 5 stars$7.11-0.8%$9.83+38.3%+41.0%$452.95M$209.36M-9.00250Positive NewsCBLLCeriBell2.5319 of 5 stars$12.06+2.2%$32.14+166.5%N/A$432.64M$65.44M-4.03N/APositive NewsSMLRSemler Scientific2.9833 of 5 stars$28.29+0.6%$81.75+189.0%+9.5%$416.31M$56.29M11.64120DCTHDelcath Systems3.0645 of 5 stars$11.55-0.9%$24.50+112.1%+11.8%$407.53M$37.21M231.0060Positive NewsBFLYButterfly Network3.1914 of 5 stars$1.60+2.2%$3.00+88.1%-13.8%$392.72M$82.06M-5.70460RXSTRxSight1.9164 of 5 stars$8.94+0.6%$10.00+11.9%-83.2%$363.74M$139.93M-11.18220Trending NewsCARLCarlsmedN/A$13.38+5.0%N/AN/A$338.64MN/A0.00100Negative NewsSNWVSanuwave Health2.0377 of 5 stars$35.92-5.2%$55.00+53.1%N/A$324.56M$32.63M-4.3540 Related Companies and Tools Related Companies ZimVie Competitors OrthoPediatrics Competitors Treace Medical Concepts Competitors CeriBell Competitors Semler Scientific Competitors Delcath Systems Competitors Butterfly Network Competitors RxSight Competitors Carlsmed Competitors Sanuwave Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
